OverviewSuggest Edit

CareDx is a global transplant diagnostics company with product offerings of the pre- and post-transplant continuum. It focuses on the discovery, development, and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. It offers the AlloMap, a gene expression testing service that helps clinicians monitor and identify heart transplant recipients with stable graft function who have a low probability of moderate-to-severe acute cellular rejection.

TypePublic
Founded2000
HQBrisbane, CA, US
Websitecaredx.com
Employee Ratings3

Latest Updates

Employees (est.) (Dec 2018)227(+35%)
Revenue (FY, 2020)$192.2 M(+52%)
Share Price (Sept 2021)$65.1(+2%)
Cybersecurity ratingAMore

Key People/Management at CareDx

Reginald Seeto

Reginald Seeto

CEO and President
Peter Maag

Peter Maag

Executive Chairman
Chris Cournoyer

Chris Cournoyer

Director
Paul Ciccolella

Paul Ciccolella

Senior Vice President, Global Operations
George Bickerstaff

George Bickerstaff

Director
Ankur Dhingra

Ankur Dhingra

Chief Financial Officer
Show more

CareDx Office Locations

CareDx has offices in Brisbane, South San Francisco, West Chester, Fremantle and in 2 other locations
Brisbane, CA, US (HQ)
3260 Bayshore Blvd
South San Francisco, CA, US
1 Tower Pl 9th floor
West Chester, PA, US
203 W Miner St
Fremantle, AU
20 Collie St
Wien, AT
Löwengasse 47/00
Stockholm, SE
Franzéngatan 5
Show all (6)

CareDx Financials and Metrics

CareDx Revenue

CareDx's revenue was reported to be $192.19 m in FY, 2020
USD

Revenue (FY, 2020)

192.2m

Net income (FY, 2020)

(18.7m)

EBIT (FY, 2020)

(22.5m)

Market capitalization (14-Sept-2021)

3.4b

Closing stock price (14-Sept-2021)

65.1

Cash (31-Dec-2020)

134.7m

EV

3.3b
CareDx's current market capitalization is $3.4 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

27.3m28.1m40.6m48.3m76.6m127.1m192.2m

Revenue growth, %

3%44%

Cost of goods sold

8.5m10.3m10.2m9.0m45.5m

Gross profit

18.8m17.9m30.4m39.3m81.6m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

6.8m6.7m7.2m7.1m7.2m6.6m10.7m12.5m11.6m12.0m12.2m14.1m17.8m21.2m26.0m31.5m28.2m38.4m36.3m45.5m

Cost of goods sold

2.4m1.8m2.7m2.5m2.6m2.8m3.1m3.4m2.3m2.2m2.1m2.3m11.5m12.4m11.9m

Gross profit

4.4m4.9m4.5m4.6m4.6m3.8m7.7m9.1m9.3m9.9m10.1m11.8m19.9m26.0m33.6m

Gross profit Margin, %

65%73%62%65%64%58%72%73%80%82%83%84%63%68%74%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

36.4m29.9m17.3m16.9m64.6m38.2m134.7m

Accounts Receivable

2.7m2.4m2.8m3.0m9.8m24.1m34.6m

Prepaid Expenses

1.4m1.8m3.6m3.8m

Inventories

686.0k766.0k5.5m5.5m4.9m6.0m10.0m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

781.0k(13.7m)(39.8m)(55.6m)(46.8m)(22.0m)(18.7m)

Depreciation and Amortization

512.0k796.0k2.9m3.8m4.2m5.5m7.0m

Inventories

(168.0k)(80.0k)492.0k1.0m363.0k(1.3m)(3.2m)

Accounts Payable

510.0k489.0k(620.0k)292.0k(168.0k)1.4m4.4m
USDQ2, 2014

Debt/Equity

-0.1 x

Debt/Assets

0.2 x

Financial Leverage

-0.2 x
Show all financial metrics

CareDx Acquisitions / Subsidiaries

Company NameDateDeal Size
XynManagementAugust 29, 2019

CareDx Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

CareDx Online and Social Media Presence

Embed Graph

CareDx News and Updates

CareDx Names Longtime Patient Advocate Art Torres to Board of Directors

Torres Adds Expertise in Regenerative Medicine and Organ Procurement to the CareDx Board Torres Adds Expertise in Regenerative Medicine and Organ Procurement to the CareDx Board

CareDx Showcases Leadership in Global Transplantation at ESOT 2021

CareDx announces the launch of AlloSeq cfDNA Research Service and demonstrates global leadership at ESOT with six abstracts and a symposium CareDx announces the launch of AlloSeq cfDNA Research Service and demonstrates global leadership at ESOT with six abstracts and a symposium

CareDx Launches ACROBAT Study to Potentially Change Care Paradigm for Stem Cell Transplant Patients

ACROBAT is the prospective multi-center study of AlloHeme, to study the potential of relapse surveillance for stem cell transplant patients ACROBAT is the prospective multi-center study of AlloHeme, to study the potential of relapse surveillance for stem cell transplant patients

CareDx to Report Second Quarter 2021 Financial Results

SOUTH SAN FRANCISCO, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today …

CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients

AlloCare launches in Android Play Store, and is now available on both iOS and Android for all transplant patients AlloCare launches in Android Play Store, and is now available on both iOS and Android for all transplant patients

CareDx Appoints Dr. Hannah Valantine to its Board of Directors

Dr. Valantine brings deep transplant and diversity leadership expertise to the CareDx board
Show more

CareDx Blogs

CareDx Reports 77% Revenue Growth for Second Quarter of 2021 and Increases Full Year Revenue Guidance

CareDx Reports 77% Revenue Growth for Second Quarter of 2021 and Increases Full Year Revenue Guidance Content Import Thu, 07/29/2021 - 16:01 CareDx Reports 77% Revenue Growth for Second Quarter of 2021 and Increases Full Year Revenue Guidance Jul 29, 2021 Thi…

Young Race Car Driver Raises Awareness About Life-Saving Transplants

Jeannine Williams saw the writing on the wall. It had been nearly 30 years since a hepatitis infection resulted in the need for a liver transplant at age 22. Decades of taking the immunosuppressive drugs required post-transplant had enabled Jeannine to live a full life, giving birth to two children …

Should Transplant Recipients Have Pets?

Alex Harrison-Flaxman is a kidney transplant recipient who understands the rollercoaster of emotions that patients face after transplant. “Being a transplant recipient is an absolute blessing, but it doesn’t come without its challenges,” says Harrison-Flaxman. “It’s a constant battle to stay vigilan…

Roasted Beet Salad with Goat Cheese, Candied Pecans, and Honey Balsamic Vinaigrette

If you need a healthy and kidney-friendly dish for any occasion, you can’t go wrong with this recipe for Roasted Beet Salad with Goat Cheese, Candied Pecans, and Honey Balsamic Vinaigrette. Courtesy of Mike Hargett of Battle Ground, Washington, the recipe is high in folate, magnesium, vitamin C, and…

CareDx Reports First Quarter 2021 Results

CareDx Reports First Quarter 2021 Results Content Import Wed, 05/05/2021 - 16:01 CareDx Reports First Quarter 2021 Results May 05, 2021 This release is a backfill from a News Wire General Releases General …

Palmetto MolDx Issues Foundational Coverage for Molecular Testing in Solid Organ Allograft Rejection

Current Medicare coverage for CareDx services remains unchanged under the new universal coverage policy SOUTH SAN FRANCISCO, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of
Show more

CareDx Frequently Asked Questions

  • When was CareDx founded?

    CareDx was founded in 2000.

  • Who are CareDx key executives?

    CareDx's key executives are Reginald Seeto, Peter Maag and Chris Cournoyer.

  • How many employees does CareDx have?

    CareDx has 227 employees.

  • What is CareDx revenue?

    Latest CareDx annual revenue is $192.2 m.

  • What is CareDx revenue per employee?

    Latest CareDx revenue per employee is $846.7 k.

  • Who are CareDx competitors?

    Competitors of CareDx include Kewaunee, Corgenix and Osler Diagnostics.

  • Where is CareDx headquarters?

    CareDx headquarters is located at 3260 Bayshore Blvd, Brisbane.

  • Where are CareDx offices?

    CareDx has offices in Brisbane, South San Francisco, West Chester, Fremantle and in 2 other locations.

  • How many offices does CareDx have?

    CareDx has 6 offices.